Skip to main content

BENDER ROBERT & ASSOCIATES

Position in LLY — ELI LILLY & Co

CIK 894300 PASADENA, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$21,162,744
+$5,017,102 QoQ
Shares Held
17,644
+0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.62%
of 13F equity value
Holder Rank
#866
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$16,486,064
PutShares
18,209

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BENDER ROBERT & ASSOCIATES holds $23,459,266 across 5 Drug Manufacturers - General names. LLY ranks #1 (90.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
17,644 $21,162,744

All Filings in LLY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,162,744 17,644
2026-03-31 $16,145,642 17,554
2025-12-31 $19,279,760 17,940
2025-09-30 $13,894,230 18,210
2025-06-30 $14,316,847 18,366
2025-03-31 $15,212,436 18,419
2024-12-31 $14,114,476 18,283
2024-09-30 $15,992,102 18,051
2024-06-30 $16,486,064 18,209
2024-03-31 $15,112,650 19,426
2023-12-31 $11,549,393 19,813
2023-09-30 $10,630,339 19,791
2023-06-30 $9,267,513 19,761
2023-03-31 $3,829,133 11,150
2022-12-31 $4,036,678 11,034
2022-09-30 $3,543,592 10,959
2022-06-30 $3,313,306 10,219
2022-03-31 $2,870,572 10,024
2021-12-31 $2,498,133 9,044
2021-09-30 $2,089,616 9,044
2021-06-30 $2,074,631 9,039
2021-03-31 $1,510,813 8,087
2020-12-31 $1,240,974 7,350
2020-09-30 $961,389 6,495
2020-06-30 $1,033,513 6,295
2020-03-31 $756,717 5,455